In breast cancer, phosphorylated-STAT3 directly induced indoleamine 2,3-dioxygenase (IDO) expression in MDSCs by binding to the promotor of IDO which is involved in immunosuppressive effects between breast cancer-derived MDSCs on T cells [37] (Fig. 2a). The gene discussed is IDO1; the disease is breast cancer.